To further explore whether siRNA can interference with Arf6 expression to inhibit the proliferation of prostate cancer cells via the PI3K/AKT signaling pathway, Western blot was conducted to detect the expression and phosphorylation of AKT, a key molecule in this pathway. Here, ARF6 is linked to prostate carcinoma.